Establishing the Safety and Efficacy of Reloxaliase in Patients With Enteric Hyperoxaluria
Clinical trial NCT03847090 · TERMINATED
Trial details
- NCT number
- NCT03847090
- Sponsor
- Allena Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-26
- Primary completion
- 2022-05-19
- Enrollment
- 92
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.